JP Morgan Chase
LABU icon

JP Morgan Chase’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

JP Morgan Chase’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Sell
2,948
-977
-25% -$187K ﹤0.01% 4781
2026
Q1 		$533K Sell
3,925
-1,243
-24% -$204K ﹤0.01% 4947
2025
Q4 		$824K Sell
5,168
-29,102
-85% -$4M ﹤0.01% 4728
2025
Q3 		$3.21M Buy
+34,270
New +$2.42M ﹤0.01% 3730
2024
Q4 		– Sell
-4,851
Closed -$625K – 7581
2024
Q3 		$625K Buy
4,851
+2,735
+129% +$357K ﹤0.01% 4760
2024
Q2 		$240K Sell
2,116
-37,335
-95% -$4M ﹤0.01% 5075
2024
Q1 		$5.24M Buy
39,451
+11,324
+40% +$1.48M ﹤0.01% 3067
2023
Q4 		$3.43M Buy
28,127
+13,881
+97% +$1.06M ﹤0.01% 3417
2023
Q3 		$1.09M Buy
14,246
+3,944
+38% +$405K ﹤0.01% 4007
2023
Q2 		$1.22M Buy
10,302
+38
+0.4% +$4.74K ﹤0.01% 3898
2023
Q1 		$1.01M Buy
+10,264
New +$1.39M ﹤0.01% 4038
2022
Q3 		– Sell
-3,072
Closed -$414K – 6672
2022
Q2 		$414K Buy
3,072
+1,247
+68% +$212K ﹤0.01% 4678
2022
Q1 		$572K Buy
1,825
+1,012
+124% +$382K ﹤0.01% 4619
2021
Q4 		$586K Buy
813
+790
+3,435% +$756K ﹤0.01% 4723
2021
Q3 		$25K Buy
23
+16
+229% +$19.7K ﹤0.01% 6000
2021
Q2 		$10K Sell
7
-27
-79% -$37.5K ﹤0.01% 6034
2021
Q1 		$53K Buy
+34
New +$79.6K ﹤0.01% 5520

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

JP Morgan Chase's LABU Position: Q2 2026 in Review

JP Morgan Chase reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 25% in Q2 2026, selling an estimated $187K and leaving 2,948 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #4781.

JP Morgan Chase first reported a position in LABU in Q1 2021 and has held it in 17 quarters since. The position peaked at $5.24M in Q1 2024. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • JP Morgan Chase held 2,948 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $860K as of Q2 2026.
  • JP Morgan Chase sold 977 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $187K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4781 holding.
  • JP Morgan Chase first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and has held it in 17 quarters since.
  • JP Morgan Chase's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.24M in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.